- Home
- HURC vs GLSI Comparison
HURC vs GLSI Comparison
Compare HURC & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURC
- GLSI
- Stock Information
- Founded
- HURC 1968
- GLSI 2006
- Country
- HURC United States
- GLSI United States
- Employees
- HURC N/A
- GLSI N/A
- Industry
- HURC Industrial Machinery/Components
- GLSI Biotechnology: Pharmaceutical Preparations
- Sector
- HURC Industrials
- GLSI Health Care
- Exchange
- HURC Nasdaq
- GLSI Nasdaq
- Market Cap
- HURC 125.1M
- GLSI 134.6M
- IPO Year
- HURC N/A
- GLSI 2020
- Fundamental
- Price
- HURC $18.22
- GLSI $12.17
- Analyst Decision
- HURC
- GLSI Strong Buy
- Analyst Count
- HURC 0
- GLSI 1
- Target Price
- HURC N/A
- GLSI $39.00
- AVG Volume (30 Days)
- HURC 24.1K
- GLSI 54.6K
- Earning Date
- HURC 09-05-2025
- GLSI 08-26-2025
- Dividend Yield
- HURC N/A
- GLSI N/A
- EPS Growth
- HURC N/A
- GLSI N/A
- EPS
- HURC N/A
- GLSI N/A
- Revenue
- HURC $183,634,000.00
- GLSI N/A
- Revenue This Year
- HURC N/A
- GLSI N/A
- Revenue Next Year
- HURC N/A
- GLSI N/A
- P/E Ratio
- HURC N/A
- GLSI N/A
- Revenue Growth
- HURC N/A
- GLSI N/A
- 52 Week Low
- HURC $13.19
- GLSI $8.06
- 52 Week High
- HURC $23.76
- GLSI $16.50
- Technical
- Relative Strength Index (RSI)
- HURC 43.94
- GLSI 58.31
- Support Level
- HURC $18.00
- GLSI $11.70
- Resistance Level
- HURC $19.34
- GLSI $12.70
- Average True Range (ATR)
- HURC 0.65
- GLSI 0.69
- MACD
- HURC -0.21
- GLSI -0.01
- Stochastic Oscillator
- HURC 10.97
- GLSI 67.28
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.